Israel-Iran war: India flags crunch in key pharma solvents used for life-saving drugs; govt moves to stabilise supply

The pharmaceutical sector's reliance on global supply chains makes it vulnerable to geopolitical events, impacting raw material availability and costs.

Neutral to cautious on the pharma sector; assess individual company's supply chain resilience.

For Indian markets, this story mainly matters for the pharma pocket. The current signal is mixed, so traders should watch whether the effect spreads across the sector or stays limited to a single name.

Watch whether the market validates this read through price action, volume, and breadth. If the headline matters, the signal should show up in execution, not just in commentary.

• •India faces challenges with essential drug ingredient supplies due to geopolitical issues.
• •Key solvents and feedstocks are impacted.
• •Drug prices are stable, and the government is taking steps to ensure availability.
• •Pro-rata allocation of feedstocks is underway; methanol supply is a concern.
• •Risk flag: Geopolitical instability impacting raw material supply